Aridis Pharmaceuticals Announces Second Quarter 2022 Financial Results and Business Update

/PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective...

Related Keywords

Wuhan ,Hubei ,China ,India ,Los Gatos ,Vu Truong ,Aridis Pharmaceuticals ,Data Safety Monitoring Committee ,Aridis Pharmaceuticals Inc ,Melinda Gates Foundation ,Prnewswire Aridis Pharmaceuticals Inc ,Cystic Fibrosis Foundation ,Innovative Medicines Initiative ,Nasdaq ,Development Expenses ,European Commission Innovative Medicines Initiative ,Paycheck Protection Program ,Serum Institute Of India ,Clinical Program ,Redchip Companies ,Company Phase ,Drug Administration ,European Commission ,Exchange Commission ,Kermode Biotechnologies Inc ,European Medicines Agency ,Gates Foundation ,Ventilator Associated Pneumonia ,Cystic Fibrosis ,Innovative Medicines ,Chief Executive Officer ,Scientific Advisory ,Quarter Financial Results ,Kermode Biotechnologies ,Administrative Expenses ,Paycheck Protection Program Loan ,Fair Value ,Note Payable ,Infectious Diseases ,Serum Institute ,Consolidated Statements ,